AbbVie Inc. (ABBV)
NYSE·Healthcare·Drug Manufacturers - General
$197.12
-0.13%
Mkt Cap $360.31B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 4, 2026 | $16.41B | $16.62B | +1.25% | $2.65 | $2.71 | +2.26% | — | — |
| Q4 2025 Oct 31, 2025 | $15.59B | $15.78B | +1.22% | $1.77 | $1.86 | +5.08% | — | — |
| Q3 2025 Jul 31, 2025 | $15.03B | $15.42B | +2.62% | $2.88 | $2.97 | +3.13% | — | — |
| Q2 2025 Apr 25, 2025 | $12.93B | $13.34B | +3.22% | $2.38 | $2.46 | +3.36% | — | — |
| Q1 2025 Jan 31, 2025 | $14.83B | $15.10B | +1.82% | $2.98 | $2.16 | -27.52% | — | — |
| Q4 2024 Oct 30, 2024 | $14.28B | $14.46B | +1.24% | $2.92 | $3.00 | +2.74% | — | — |
| Q3 2024 Jul 25, 2024 | $14.02B | $14.46B | +3.14% | $2.57 | $2.65 | +3.11% | — | — |
| Q2 2024 Apr 26, 2024 | $11.93B | $12.31B | +3.19% | $2.26 | $2.31 | +2.21% | — | — |
| Q1 2024 Feb 2, 2024 | $12.98B | $14.30B | +10.20% | $2.76 | $2.79 | +1.09% | — | — |
| Q4 2023 Oct 27, 2023 | $13.67B | $13.93B | +1.87% | $2.86 | $2.95 | +3.15% | — | — |
| Q3 2023 Jul 27, 2023 | $13.52B | $13.87B | +2.58% | $2.79 | $2.91 | +4.30% | — | — |
| Q2 2023 Apr 27, 2023 | $12.17B | $12.22B | +0.47% | $2.44 | $2.46 | +0.82% | — | — |
| Q1 2023 Feb 9, 2023 | $15.33B | $15.12B | -1.37% | $3.54 | $3.60 | +1.69% | — | — |
| Q4 2022 Oct 28, 2022 | $14.96B | $14.81B | -0.99% | $3.56 | $3.66 | +2.81% | — | — |
| Q3 2022 Jul 29, 2022 | $14.66B | $14.58B | -0.56% | $3.31 | $3.37 | +1.81% | — | — |
| Q2 2022 Apr 29, 2022 | $13.61B | $13.54B | -0.55% | $3.14 | $3.24 | +3.18% | — | — |
| Q1 2022 Feb 2, 2022 | $14.95B | $14.89B | -0.44% | $3.29 | $3.31 | +0.61% | — | — |
| Q4 2021 Oct 29, 2021 | $14.35B | $14.34B | -0.08% | $3.23 | $3.33 | +3.10% | — | — |
| Q3 2021 Jul 30, 2021 | $13.96B | $13.96B | +0.00% | $3.11 | $3.11 | +0.00% | — | — |
| Q2 2021 Apr 30, 2021 | $12.81B | $13.01B | +1.58% | $2.77 | $2.95 | +6.50% | — | — |